高级检索
当前位置: 首页 > 详情页

Open-neck organ preservation surgery for hypopharyngeal cancer: indications, techniques, limits, and outcomes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Head and Neck Surgical Oncology, Nottingham University Hospitals, Queens Medical Centre Campus, Nottingham, UK [2]Department of Otolaryngology, Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: hypopharyngeal cancer open-neck surgery partial laryngopharyngectomy partial pharyngectomy reconstructive surgery

摘要:
Purpose of review To appraise the practice and role of open-neck organ preserving surgery for hypopharyngeal squamous cell carcinoma and to update the current indications, techniques, limits, and outcomes. Recent findings The role of primary surgery for hypopharyngeal carcinoma has shifted over the past two decades to primary nonsurgical management with the use of induction or concurrent chemoradiotherapy. The preferred and most suitable tumours for open-neck surgery are the small-volume T stage diseases, with small to medium-volume neck metastases, however such patients are exceedingly rare. Nonetheless, more advanced tumours with cartilage invasion, vocal cord paralysis, or located at piriform apex and postcricoid area, previously unsuitable for open-neck organ preserving surgery, can now be excised and repaired, minimizing morbidity and improving quality of patients' life. Much of this surgical progress has been developed by innovative surgeons using free tissue transfer, accurate placement surgery, reconstruction of a neoglottis, and perfecting the pharyngoesophageal anastomosis. Current practice of open-neck organ preserving surgery for hypopharyngeal carcinoma has been mainly reported in Asia: Korea, Taiwan, Japan, and China. Summary There are some patients who are deemed unsuitable and/or unwilling for current treatment by nonsurgical approaches, and open-neck organ preserving laryngopharyngeal surgery may be a more suitable alternative than selecting a 'lesser or modified' chemo or bioradiotherapy regimen, resulting in a prolonged quantity and quality of life.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版
大类 | 4 区 医学
小类 | 3 区 耳鼻喉科学
最新[2025]版
大类 | 3 区 医学
小类 | 3 区 耳鼻喉科学
JCR分区:
出版当年[2017]版:
Q3 OTORHINOLARYNGOLOGY
最新[2023]版:
Q2 OTORHINOLARYNGOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Head and Neck Surgical Oncology, Nottingham University Hospitals, Queens Medical Centre Campus, Nottingham, UK [*1]10 Chartwell Grove, Mapperley Plains, Nottingham NG3 5RD, UK.
通讯作者:
通讯机构: [1]Head and Neck Surgical Oncology, Nottingham University Hospitals, Queens Medical Centre Campus, Nottingham, UK [*1]10 Chartwell Grove, Mapperley Plains, Nottingham NG3 5RD, UK.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)